Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. STKE, 10 April 2007
Vol. 2007, Issue 381, p. eg2
[DOI: 10.1126/stke.3812007eg2]

EDITORIAL GUIDES

Focus Issue: Exploring New Avenues for Cancer Treatment

Elizabeth M. Adler1* and Nancy R. Gough2

1 Associate Editor of Science's STKE,
2Editor of Science's STKE, American Association for the Advancement of Science, 1200 New York Avenue, N.W., Washington, DC 20005, USA.

Abstract: This issue of Science’s STKE features research into the pathophysiology of cancer cells. The featured articles describe how malignancy may arise due to the subversion of normal cellular functions, the signaling pathways involved, and new approaches to cancer therapy that involve the exploitation of oncogenic changes. The research presented provides an optimistic outlook for translating new understanding of cell signaling into novel therapies.

*Corresponding author. E-mail: eadler{at}aaas.org.

Citation: E. M. Adler, N. R. Gough, Focus Issue: Exploring New Avenues for Cancer Treatment. Sci. STKE 2007, eg2 (2007).

Read the Full Text



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882